Previous Article | Next Article ![]()
Mol. Cell. Biol., 01 1995, 255-263, Vol 15, No. 1
X Leng, J Blanco, SY Tsai, K Ozato, BW O'Malley and MJ Tsai
Steroid, thyroid, and retinoid hormones exert their biological functions by
interacting with their cognate nuclear receptors. Upon binding receptors,
hormones induce a protease-resistant structural change in the receptor
ligand-binding domain and subsequently activate the receptors. Utilizing
partial proteolysis, we have been able to delineate a region in the mouse
retinoid X receptor beta (mRXR beta) required for ligand binding. A
separable activation domain within the mRXR beta E region has been
identified. The activation domain, which is 21 amino acids in length, is
located at the extreme C terminus of mRXR beta. This domain is not required
for ligand binding since removal of this sequence neither eliminates the
ligand-induced, protease-resistant conformational change nor alters the
ligand-enhanced DNA binding. Furthermore, deletion of this activation
domain converts the receptor into a transcriptional silencer. Finally, a
further truncation of 9 amino acids (for a total of 30 amino acids) from
the C terminus results in a mutant which does not undergo the
protease-resistant conformational change and cannot bind DNA as a
homodimer. Nevertheless, this mutant is still able to form a heterodimer
with the thyroid hormone receptor. Therefore, homodimerization and
heterodimerization can be distinguished by this nine-amino-acid sequence.
Copyright © 1995, American Society for Microbiology
Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region
Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|